肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

英国启动阿司匹林抗癌症复发试验，预计纳入1.1万人

2015-10-24 MedSci MedSci原创

阿司匹林癌症
关注

英国开启世界上最大规模的临床试验，测试阿司匹林的抗癌效果。 据国外媒体报道，英国将启动世界上最大的临床试验测试阿司匹林的抗癌效果。大约有1.1万曾患有早期肠癌、乳腺癌、前列腺癌、胃癌以及食道癌的人们将参与这项实验。 最近几年，关于阿司匹林是否具有抗癌效果的争论由于其不确定性而越演越烈。科学家称，如果证实这种药物的效果，那么它将带来革命性变化，为癌症患者提供一种廉价而有效的治疗方

英开启史上最大临床试验 超万人参与抗癌测试

英国开启世界上最大规模的临床试验，测试阿司匹林的抗癌效果。
 
据国外媒体报道，英国将启动世界上最大的临床试验测试阿司匹林的抗癌效果。大约有1.1万曾患有早期肠癌、乳腺癌、前列腺癌、胃癌以及食道癌的人们将参与这项实验。
 
最近几年，关于阿司匹林是否具有抗癌效果的争论由于其不确定性而越演越烈。科学家称，如果证实这种药物的效果，那么它将带来革命性变化，为癌症患者提供一种廉价而有效的治疗方式。
 
这项临床试验是由英国慈善癌症研究中心和英国国家健康研究所共同资助的，病患们将在5年时间里每天服用一片阿司匹林。研究人员将把服用不同剂量的患者与那些服用安慰剂的患者进行比对，并检查癌症是否复发。
 
英国癌症研究中心的Fiona Reddington博士称：“这项临床试验特别令人激动，因为癌症复发通常难以治愈，因此找到一种廉价而有效的抗癌方式有可能给病患们带来革命性的变化。”
 
这项临床试验将在英国的100家医疗机构中进行，许多患有或者已经治愈早期癌症的患者们将参与其中，这项实验将持续长达12年时间。每天服用药物也会带来一系列的健康问题，因为它可能带来副作用，比如说胃溃疡和胃出血等。
 
这项实验的首席研究员Ruth Langley教授称：“已经有一些有趣的研究表明阿司匹林能够延迟或者阻止早期癌症的复发，但是尚未有随机试验提供清晰的证据。这项实验的目的就是为了彻底解决这一问题。”
 
Ruth教授声称：“如果我们的研究表明阿司匹林确实能够阻止癌症反复，它就能够完全改变未来的治疗，为我们提供一种阻止癌症反复的简单而廉价的方式，并且帮助更多的人存活下来。”
 
51岁的Alex King在2009年12月被诊断为乳腺癌，现在已经治愈。他声称：“患癌是我生命中最糟糕的经历，任何能够减少癌症复发的机会都是非常重要的。”许多人现在已经每天服用小剂量的阿司匹林，将其作为一种心脏病药物。

与阿司匹林相关的拓展阅读：

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-26 yhtmyf

    那万一胃出血呢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-26 lq0302

    #癌症复发#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 fatalmelanie

    神奇阿司匹林

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 yaolv

    谢谢分享！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 Troubleisme

    感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=41405, encodeId=aa6f41405bd, content=那万一胃出血呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ad96971, createdName=yhtmyf, createdTime=Mon Oct 26 21:24:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425278, encodeId=a92f14252e827, content=<a href='/topic/show?id=7eb6e134273' target=_blank style='color:#2F92EE;'>#癌症复发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71342, encryptionId=7eb6e134273, topicName=癌症复发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad3959854, createdName=lq0302, createdTime=Mon Oct 26 13:06:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41041, encodeId=0ce14104185, content=神奇阿司匹林, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Sun Oct 25 12:55:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41027, encodeId=38af4102e83, content=谢谢分享！, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fc61653254, createdName=yaolv, createdTime=Sun Oct 25 12:11:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40975, encodeId=7c75409e5df, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151025/IMG562C3D4B3EFBE1123.jpg, createdBy=05d41658943, createdName=Troubleisme, createdTime=Sun Oct 25 10:22:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40900, encodeId=a6744090008, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40901, encodeId=9b70409019a, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:03:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40897, encodeId=15e94089e66, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40898, encodeId=5a394089827, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40899, encodeId=127440899db, content=这篇文章写得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 25 10:02:00 CST 2015, time=2015-10-25, status=1, ipAttribution=)]
    2015-10-25 hlycom3356

    这篇文章写得非常好

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

高血压患者服用阿司匹林3大注意！

阿司匹林治疗的适宜人群 2006 年 AHA/ASA 动脉粥样硬化事件一级预防指南建议，阿司匹林应长期用于 10 年心血管事件风险超过 6%~10% 的人群，以防止首次心脑血管事件的发生(Ⅰ 级推荐，A 级证据)。根据试验荟萃和指南，结合心血管疾病风险评估表，如果没有禁忌，以下 3 类高血压患者应考虑使用阿司匹林：①≥50 岁单纯高血压人群，血压控制良好，无禁忌;②<50

ECC 2015：阿司匹林抗癌效果突出，肿瘤患者生存时长可翻倍

根据2015年欧洲癌症大会的观点，阿司匹林可使胃肠道癌症患者的生存几率翻倍。 荷兰莱顿大学医学中心Martine Frouws博士领导的研究团队指出，他们有越来越多的证据表明阿司匹林可用于预防和治疗癌症，且效果卓著。 上个月,Medical News Today报道了一项研究，表明阿司匹林可以降低民众患结直肠癌的风险。而一项最近的研究指出，阿司匹林可能有助于提高乳腺癌、皮肤癌和肠道癌症患者的治疗效

Mol Med：阿司匹林抗炎抗肿瘤真相揭秘

最近，科学家们发现阿司匹林的主要成分---水杨酸（Salicylic Acid）可以从功能上阻断在人体内引起炎症的元凶----HMGB1，一种晚期炎症蛋白，就是它积极参与了各种严重危害人类健康的疾病发生，如风湿性关节炎，心脏病，败血症和一些炎症有关的癌症，譬如肠癌。美国康奈尔大学和其附属研究所Boyce Thompson Institute (BTI)的科学家们在“分子医学”杂志上发表了他们的

植物源的药物：阿司匹林，青蒿素，二甲双胍......

青蒿素，砒霜是国人熟悉的源于植物和天然矿物的两种药物。实际上，我们日常使用的药物中，有很多源于植物，包括中药。象很多化疗药物，如紫杉醇，长春新碱，喜树碱等等。而经典药物中，源于植物的，甚至长盛不衰的还有很多，最牛的算是阿司匹林和二甲双胍了。 阿司匹林可能大家都知道，源于柳树皮。但是，二甲双胍，可能就很少有人知道它的来源了。实际上，最初也是源于植物。 从山羊豆说起 山羊豆（Galega o

Int J Stroke：急性卒中或TIA患者阿司匹林或替卡格雷抗血小板治疗与预后（试验设计）

背景：缺血性卒中和短暂性脑缺血发作（TIA）急性期时，患者易再发缺血。阿司匹林是指南推荐用药，但是更加强化抗血小板的治疗可能是合理的。目的：研究人员旨在评估非严重缺血性卒中或者高危TIA发生24h后，与应用阿司匹林相比，替卡格雷是否能减少重大血管事件发生的风险。替比格雷是一种阻断P2Y12这种不需要代谢活性受体的药物。设计：应用阿司匹林或替卡格雷治疗急性卒中或者TIA患者以及患者预后（SOCRAT

ASRM 2015：阿司匹林助你怀孕

今年在巴尔的摩召开的美国生殖医学协会年会上有研究人员指出，每日服用低剂量的阿司匹林可有助于女性怀孕，尤其是既往有流产史的女性。犹他大学和NICHD的研究人员表明，若女性每日服用81mg阿司匹林，则可降低女性体内的炎症反应，改善胚胎生长环境，进而有助于女性受孕。 阿司匹林是一种水杨酸药物，通常用于治疗发热、炎症和缓解轻微疼痛等，此外可以作为抗血小板药物，以降低具有患心脏病和中风高危风险的民众的发